Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Famotidine vs Oral Antacids for Dyspepsia in the ED
NCT06241183Phase 4Recruiting
- Sponsor
- Stony Brook University
- Start
- Nov 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of famotidine in dyspepsia, sponsored by Stony Brook University. Started Nov 2023; status: recruiting.
02
Drugs
famotidine
03
Conditions
dyspepsia
Beyond the preview
Go deeper on NCT06241183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06241183.